CDKN2A and glioblastoma: This study is the first to elucidate the molecular mechanism through which CA induces the G0/G1 phase arrest in GBM cells by interfering with EZH2, thereby alleviating the inhibitory effect of PRC2 on p27 and p16 (Figure 7).